Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-national Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients With Haemophilia A

NCT01480180 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01480180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01480180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-national Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients With Haemophilia A
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
January 30, 2012
Completion date
December 10, 2018
Enrollment
186 (actual)
Sites
93

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a